Knowledge Base Retrieval and Recall for Recombinant Protein Clinical Trial Pre-screening

Recombinant protein clinical trial pre-screening involves diverse data sources. These primarily include clinical trial registries (e.g.

Data Characteristics for This Category

Recombinant protein clinical trial pre-screening involves diverse data sources. These primarily include clinical trial registries (e.g., ClinicalTrials.gov), internal reports from biopharmaceutical companies, academic journals, patent literature, and documents published by drug regulatory agencies (e.g., FDA, EMA). Data update frequencies vary; clinical trial registration information may update weekly, while academic papers and patents have longer update cycles. Document structures differ: clinical trial protocols often exist as structured PDFs, containing sections like study design, inclusion/exclusion criteria, and endpoint indicators. Internal reports and patents are often unstructured text, mixed with charts and figures. Field-wise, recombinant protein data includes specific fields such as protein sequence, expression system, purification method, antigenicity, and immunogenicity. Some data contains physicochemical properties like molecular weight (unit kDa), isoelectric point (pI), and affinity (unit nM).

Constraints Imposed by These Characteristics on Knowledge Base Retrieval and Recall

The sequence information and structural complexity of recombinant proteins mean traditional keyword-based retrieval can easily miss or incorrectly retrieve relevant information. The large volume of unstructured text requires the knowledge base to have strong text parsing and semantic understanding capabilities. Inclusion/exclusion criteria in clinical trial protocols often involve complex logical relationships and numerical ranges; traditional segmentation methods might fragment this critical information, affecting recall accuracy. For physicochemical property fields like molecular weight and affinity, their numerical ranges and units require precise matching or range queries during retrieval. This demands that the knowledge base can handle numerical data with units. Furthermore, differing update frequencies across data sources necessitate incremental updates and version management for the knowledge base to avoid retrieving outdated information.

Configuration Guidelines

Configuration ItemRecommended ValueRationale for This Value
Chunk size800–1200 charactersPreserves the contextual integrity of long paragraphs in clinical trial protocols, preventing critical information from being truncated.
Chunk Overlap Length100 charactersEnsures semantic continuity at paragraph boundaries, especially when describing complex inclusion/exclusion criteria.
Recall countTop 8–12 entriesBalances recall breadth with the efficiency of subsequent re-ranking, increasing the probability of covering relevant protein variants or similar trials.
Similarity thresholdCalibrate based on actual measurementsThe semantic similarity of recombinant protein sequences and functional descriptions is not uniform and requires adjustment based on actual query performance.
embedding_modeltext-embedding-ada-002 or bge-large-zhBalances encoding efficiency with semantic representation capability, effectively capturing the deep meaning of protein-related terminology.
Rerank result countTop 3–5 entriesFocuses on the most relevant recombinant protein trials for the query, reducing the burden of manual screening.

Three Common Mistakes

  • After uploading knowledge base documents, critical inclusion/exclusion criteria or protein characteristic descriptions are missing from retrieval results. This can happen if document segment length is too short, causing important information to be truncated or scattered across different segments.
  • When retrieving clinical trials for a specific recombinant protein, many irrelevant results are returned, or highly relevant trials are missed. This can happen if Similarity threshold is set incorrectly, failing to effectively differentiate subtle variations in protein sequences, targets, or indications.
  • System logs show a 422 Unprocessable Entity error, indicating an inability to process documents containing images or complex tables. This can happen if the knowledge base's document parser does not support text embedded within specific image formats or complex table structures, leading to content extraction failure.

How to Confirm Correct Configuration

  • Select 5–10 typical recombinant protein clinical trial pre-screening queries. Check if the recall results include all expected key information points, such as protein name, target, indication, and core terms of inclusion/exclusion criteria.
  • For the query results, check the contextual integrity of the recalled segments. Confirm that no critical sentences or numerical ranges are unreasonably split.
  • Compare result differences under various Recall count and Similarity threshold configurations. Find a configuration range that balances recall rate and accuracy.
  • Upload recombinant protein-related literature containing complex charts and formulas. Confirm that the knowledge base can correctly parse and extract text content, and that this information can be effectively associated during retrieval.

The values provided are common starting points and should be measured against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.